CNSP - Cns Pharmaceuticals Inc
2.94
-0.060 -2.041%
Share volume: 22,735
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$3.00
-0.06
-0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-15-2024 | 08-14-2024 | 11-14-2024 | 05-15-2025 | 08-14-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 1.661 M | 2.469 M | 7.409 M | 13.749 M | 14.508 M | 11.869 M | |
| Current Assets | 1.601 M | 2.145 M | 7.388 M | 13.722 M | 14.138 M | 11.392 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 16.750 K | 26.932 K | 0.000 | 14.173 K | 43.700 K | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 815.226 K | 1.492 M | 6.973 M | 13.048 M | 12.130 M | 9.864 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 4.305 K | 3.553 K | 2.802 K | 4.905 K | 3.804 K | 3.107 K | |
| Other Assets | 55.296 K | 320.320 K | 18.373 K | 0.000 | 366.251 K | 474.416 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 1.661 M | 2.469 M | 7.409 M | 13.749 M | 14.508 M | 11.869 M | |
| Total liabilities | 6.091 M | 6.763 M | 4.057 M | 2.779 M | 1.383 M | 1.959 M | |
| Total current liabilities | 6.091 M | 6.763 M | 4.057 M | 2.779 M | 1.383 M | 1.959 M | |
| Accounts Payable | 5.878 M | 6.640 M | 4.026 M | 2.569 M | 1.261 M | 1.928 M | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -4.431 M | -4.294 M | 3.352 M | 10.970 M | 13.125 M | 9.910 M | |
| Common stock | 68.681 M | 71.349 M | 84.601 M | 99.696 M | 104.226 M | 104.230 M | |
| Retained earnings | -73.112 M | -75.642 M | -81.248 M | -88.726 M | -91.101 M | -94.319 M |